Rahsaan W. Thompson - 14 Aug 2026 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Reporting relationship: Chief Legal & Compliance
Issuer ticker: ZVRA
Reported as of: 14 Aug 2026
Net transaction value: -$474,774
SEC form: 4
Accepted by SEC: 17 Aug 2026, 16:32:42 UTC
Prior SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Rahsaan W. Thompson

Key filing fact

Rahsaan W. Thompson filed Form 4 for ZEVRA THERAPEUTICS, INC. (ZVRA) on 17 Aug 2026.

Key facts

This page summarizes Rahsaan W. Thompson's Form 4 filing for ZEVRA THERAPEUTICS, INC. (ZVRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2026, 16:32.

Change

Previous filing in this sequence was filed on 23 Jun 2026.
Current net transaction value: -$474,774.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001788524 Primary reporting owner

Thompson Rahsaan

Relationship: Chief Legal & Compliance
Address: C/O ZEVRA THERAPEUTICS, INC., 101 FEDERAL STREET, BOSTON
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Rahsaan W. Thompson
Signature date: 17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZVRA transaction

Common Stock

Sale

Transaction value: $474,774
Shares: -42,666
Change %: -53%
Price: $11.13
Shares after: 37,569
Date: 14 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Adoption date of referenced 10b5-1(c) plan is: 05-15-2026

Footnote F2

This transaction was executed in multiple trades at prices ranging from $10.86 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.